Rhenman & Partners Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $16.7M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $7.67M | Sell |
|
|||||
|
2022
Q4 | $17.9M | Hold |
|
|||||
|
2022
Q3 | $16.3M | Sell |
|
|||||
|
2022
Q2 | $28.3M | Buy |
|
|||||
|
2022
Q1 | $27.1M | Sell |
|
|||||
|
2021
Q4 | $58.4M | Hold |
|
|||||
|
2021
Q3 | $43M | Buy |
|
|||||
|
2021
Q2 | $19.6M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $147K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $213K | Hold |
|
|||||
|
2018
Q4 | $219K | Sell |
|
|||||
|
2018
Q3 | $386K | Hold |
|
|||||
|
2018
Q2 | $318K | Hold |
|
|||||
|
2018
Q1 | $311K | Sell |
|
|||||
|
2017
Q4 | $377K | Hold |
|
|||||
|
2017
Q3 | $372K | Sell |
|
|||||
|
2017
Q2 | $14.5M | Buy |
|
|||||
|
2017
Q1 | $11.5M | Buy |
|
|||||
|
2016
Q4 | $10.8M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $13.2M | Sell |
|
|||||
|
2016
Q1 | $14.1M | Buy |
|
|||||
|
2015
Q4 | $14.1M | Buy |
|
|||||
|
2015
Q3 | $13.2M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $11.3M | Buy |
|